NCI ‘Last Mile’ Initiative Innovates Self-Sampling for HPV Screening
New self-sampling technologies screening for HPV could help increase access and reduce cervical cancer among underserved and high-burden populations.
The National Cancer Institute’s Last Mile initiative is exploring new ways at getting screening tests for cervical cancer into more hands. Women who die from cervical cancer often have had limited or no access to screenings. This is just one element that has largely driven the White House’s Cancer Moonshot Program to significantly reduce the death rate from cancer over the coming years.
Dr. Vikrant Sahasrabuddhe, deputy chief of the Breast and Gynecologic Cancer Research Group and Program Director in the Division of Cancer Prevention at NCI, discusses more about how technology and research are driving the Last Mile initiative and how it is reducing health inequities by reaching women where they are with more at-home screening options. Sahasrabuddhe also highlights how advancements with tools like AI are improving diagnosing and treating cervical cancer.
-
Dr. Vikrant Sahasrabuddhe Program Director, Division of Cancer Prevention NCI
-
NIH Leader: AI Must Do the Right Thing, Not Just Do It Right
NIH's Joe Croghan discusses AI ethics, human oversight, risk management and how the Biogenesis initiative could accelerate biomedical research.
7m watch -
How Edge AI Is Shaping the Future of Federal Missions
HP's Leif Olson discussed how edge AI can help federal agencies strengthen security, control costs and improve mission efficiency.
9m watch -
AI Drives Cybersecurity Strategies Beyond Patching to Thwart Vulnerabilities
NinjaOne's Egon Rinderer discussed how AI-driven cyber threats are changing vulnerability management and why agencies need to move beyond patching.
20m watch -
How Zero Trust Can Help Agencies Secure Emerging AI Capabilities
Island's Monty Montgomery discussed how zero trust can help federal agencies secure AI systems and manage emerging risks.
6m watch